For the Inventor, By the Inventor

Enter assignee name

Ashland, VA, United States of America

Lyotropic Therapeutics, Inc.

USPTO Granted Patents = 24

CIPO Patents = 3

EPO Patents = 1

Trademarks = 3

Forward Citations = 340

Loading Chart...

Loading Chart...

4 inventors (with patents filed for the assignee):

David Anderson (24 out of 24 patents)

Benjamin G Cameransi, Jr (11 out of 11 patents)

Vincent M Conklin (11 out of 11 patents)

4. Richard G Saul (2 out of 7 patents)

5. Benjamin Cameransi (0 patent)

6. David M Anderson (0 patent)

7. Benjamin G Cameransi (0 patent)

8. David M Anderson (0 patent)

24 patents: Sort by Forward Citations

1. 10821098 - Treatment using dantrolene (2020-11-03),

2. 10314822 - Treatment using dantrolene (2019-06-11),

3. 9884044 - Treatment using dantrolene (2018-02-06),

4. 9789090 - Treatment using dantrolene (2017-10-17),

5. 9603840 - Treatment using dantrolene (2017-03-28),

6. 9394339 - Stabilized formulations of peptides and proteins protecting against non-enzymatic degradation (2016-07-19),

7. 9271964 - Treatment using dantrolene (2016-03-01),

8. 8858927 - Method for protection of peptides or proteins against non-enzymatic deamidation (2014-10-14),

9. 8728829 - Compositions for binding to assay substrata and methods of using (2014-05-20),

10. 8685460 - Treatment using dantrolene (2014-04-01),

11. 8604072 - Treatment using dantrolene (2013-12-10),

12. 8449863 - Stabilized uncoated particles of reversed liquid crystalline phase materials (2013-05-28),

13. 8128906 - Stabilized uncoated particles of reversed liquid crystalline phase materials (2012-03-06),

14. 8128905 - Stabilized uncoated particles of reversed liquid crystalline phase materials (2012-03-06),

15. 8110225 - Treatment using dantrolene (2012-02-07),

Lyotropic Therapeutics, Inc. is a biopharmaceutical company specializing in the development of novel drug delivery systems. With a focus on lyotropic liquid crystal technology, our innovative formulations enhance the delivery of therapeutics across various routes of administration. Through our cutting-edge research and partnerships, we aim to improve patient outcomes and revolutionize the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

24 Patents

#1 in Ashland, VA

#239 in Virginia

#13,448 in US

#25,908 in the World

Ashland, VA, United States of America

Lyotropic Therapeutics, Inc.

Forward Citations = 340

4 inventors:

David Anderson (24 out of 24 patents)

Benjamin G Cameransi, Jr (11 out of 11 patents)

Vincent M Conklin (11 out of 11 patents)

4. Richard G Saul (2 out of 7 patents)

5. Benjamin Cameransi (0 patent)

Please report any incorrect information to support@idiyas.com

Loading…